In Saccharomyces cerevisiae, the essential function of amino-terminal methionine removal is provided cotranslationally by two methionine aminopeptidases (MetAP1 and MetAP2). To examine the individual processing efficiency of each MetAP in vivo, we measured the degree of N-terminal methionine cleavage from a series of mutated glutathione-S-transferase (GST) proteins isolated from yeast wild-type, a map1 deletion strain, a map2 deletion strain, and a map1 deletion strain overexpressing the MAP2 gene. We found that MetAP1 plays the major role in N-terminal methionine removal in yeast. Both MetAPs were less efficient when the second residue was Val, and MetAP2 was less efficient than MetAP1 when the second residue was Gly, Cys, or Thr. These findings indicate that MetAP1 and MetAP2 exhibit different cleavage efficiencies against the same substrates in vivo. Interestingly, although methionine is considered a stabilizing N-terminal residue, we found that retention of the initiator methionine on the Met-Ala-GST mutant protein drastically reduced its half-life in vivo. © 2002 Elsevier Science
Biosynthesis of protein is initiated with either methionine (in eukaryotes) or formylmethionine (in prokaryotes, mitochondria, and chloroplasts) (1) (2) (3) . Where formylmethionine is used, the formyl group is removed by a deformylase, resulting in a methionine residue with a free NH 2 group (4, 5) . In both prokaryotes and eukaryotes, the N-terminal methionine is often cleaved by methionine aminopeptidase (MetAP) 3 if the second residue in the primary sequence is small and uncharged (e.g., Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val) (1, 3, 6 -9) . The newly exposed N-terminus may then be subject to additional cotranslational modifications such as N ␣ -acetylation (10) or N ␣ -myristoylation (11) . Many proteins may require processing by MetAP for biological activity. These proteins are involved in a variety of biological processes including DNA repair, signal transduction, cell transformation, secretory vesicular trafficking, and viral capsid assembly/infection (12) .
There are two classes of methionine aminopeptidase, designated MetAP1 and MetAP2. Both are metalloenzymes that cotranslationally cleave N-terminal methionine when the second residue is small and uncharged (13) (14) (15) (16) (17) (18) (19) (20) . X-ray structures have been determined for MetAP1 from Escherichia coli (21, 22) and for MetAP2 from Pyrococcus furiosus (23) and human (24) . Although the two types of MetAPs share only ϳ20% identity in amino-acid sequence, they both fold into very similar three-dimensional structures (25) .
Eubacteria contain only one type of methionine aminopeptidase gene (MAP). Deletion of this gene from E. coli (15) or Salmonella typhimurium (16) is lethal. Saccharomyces cerevisiae expresses both a MAP1 (18) and a MAP2 gene (19) . Deletion mutants of either the MAP1 (18) or the MAP2 gene are viable in yeast, but deletion of both genes is lethal (19) , indicating that N-terminal methionine removal is an essential function in yeast, as in bacteria.
Unlike bacterial MetAPs, eukaryotic MetAPs have an extended N-terminal region. Within this region, MetAP1 has two zinc finger motifs and MetAP2 has a highly charged N-terminal region. These N-terminal domains have been predicted to mediate the presumed association of MetAPs with the ribosomes (18, 19) . In the C-terminal catalytic domain of both MetAPs, amino acid residues involved in metal binding are all conserved (19) . However, comparison of the 3-D structures from E. coli MetAP (MetAP1) and human MetAP2 reveal that there are differences in the substrate binding pocket of their active sites (24) .
The N-terminal methionine removal/N-terminal acetylation pattern has been characterized in yeast by analysis of mutant yeast iso-1-cytochrome c proteins (7, 9) and mutants of the plant protein thaumatin (8) . These studies, however, were carried out in wild-type yeast where the activities of MetAP1 and MetAP2 could not be distinguished.
In this report, we provide the first examination of the individual Met cleavage pattern of each MetAP in vivo using yeast strains in which the presence of one or the other MetAP has been eliminated. By analyzing the degree of methionine cleavage of a series glutathione S-transferase (GST) mutant proteins altered at the second residue, we found that the two MetAPs exhibit a different substrate cleavage pattern in vivo. Interestingly, although methionine is considered a stabilizing residue, we found that retention of the initiator methionine for one mutant protein drastically reduced its half-life in vivo.
MATERIALS AND METHODS
Strains and plasmid vectors. All yeast strains used in this report are isogenic and differ only at the MAP1 or MAP2 locus. All strains were derived from W303-1A (MATa ade2-1 can1-100 ura3-1 leu2-3,112 trp1-1 his3- 11, 15) . YS401 (map1::HIS3) is a map1⌬ strain (18) . YS402 (map2::URA3) is a map2⌬ strain (26) . YS403 (map1::HIS3 p425GPD/MAP2) is a map1⌬ strain that overexpresses the MAP2 gene under the yeast glyceraldehyde-3-phosphate promoter (GPD). The yeast expression vector p425GPD (27) is from ATCC.
DNA constructs. The gene encoding Schistosoma japonicum glutathione S-transferase (GST) (EC 2.5.1.18) was amplified by polymerase chain reaction (PCR) with the oligonucleotide primers
Restriction sites (SpeI and PstI) were incorporated at the ends of the PCR product, which was inserted into the multicopy yeast expression vector p425GPD. In this plasmid, the expression of the GST gene is under the control of the strong yeast GPD promoter. To generate point mutants at the second residue, different mutagenic oligonucleotide PCR primers were used to amplify the GST gene (28) . The products were subcloned into the p425GPD vector. In these mutagenic primers, the TCC codon for the wild-type residue Ser was replaced by a codon for Ala, Cys, Gly, Pro, Thr, Val, Gln, Glu, or Leu (Fig. 1) . All recombinant plasmids were sequenced using the Sequenase II kit (US Biochemical, Cleveland, OH).
Expression and purification of GST protein. Each p425GPD plasmid containing a GST gene was used to transform yeast wild type (W303-1A), and MAP deletion strains YS401, YS402, YS403. To purify each recombinant GST protein, 600 ml of yeast cells were grown in synthetic medium at 30°C to ABS 600 ϭ 2, harvested by centrifugation, and resuspended in 5 ml MTPBS [150 mM NaCl, 16 mM Na 2 HPO 4 , 4 mM NaH 2 PO 4 (pH 7.3), 1% Tween 20, and 5 l of a protease inhibitor cocktail (Sigma)]. Crude extracts were obtained by vortexing with 3 g of acid-washed glass beads (0.5-mm diameter) for 1 min, alternating with cooling on ice for 1 min, for a total of 5 cycles. After centrifugation at 15,000 rpm for 15 min, the supernatant was loaded onto a 2-ml column of glutathione-agarose beads (Sigma). After three washes with 10 ml of MTPBS, the protein was eluted with 1 ml of 50 mM Hepes buffer, pH 7.5, containing 10 mM of freshly prepared reduced glutathione (Sigma). The purity of GST was analyzed by SDS-PAGE, followed by staining with Coomassie brilliant blue. The fractions containing purified GST were pooled and lyophilized. The lyophilized GST was dissolved in 0.1% TFA and FIG. 1. DNA construct. To generate a point mutant at the second residue of glutathione-S-transferase, different mutagenic oligonucleotide PCR primers were used to amplify the GST gene. Each mutant GST gene was subcloned into the p425GPD vector. In these mutant GST genes, the TCC codon for the wild-type residue Ser was replaced by codons for Ala, Cys, Gly, Pro, Thr, Val, Gln, Glu, or Leu, respectively.
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CHEN, VETRO, AND CHANG further purified by reverse-phase HPLC using a C 18 column (3.9 ϫ 150 cm). After washing the column with 10 ml of 0.1% TFA, the bound protein was eluted with a linear gradient of 0 -70% acetonitrile on 0.1% TFA at a flow rate of 1.0 ml/min. The signals were detected at 280 nm. GST-containing fractions were pooled, lyophilized, and analyzed by electrospray mass spectrometry (ESI-MS).
Determination of the mass of GST expressed in different yeast strains. The mass of each purified GST was analyzed using a Perkin-Elmer API 100 SCIEX electrospray mass spectrometer. Purified GST samples were introduced into the analyzer at a rate of 4.0 ml/min. The positive and negative ions generated by the ion evaporation process entered the analyzer through an interface plate with a 100-m orifice. The declustering potential was maintained between 50 and 200 V to control the collisional energy of the entering ions.
Pulse-chase labeling experiments. Wild-type and mutant S. cerevisiae expressing the S2A mutant protein or wild-type GST were grown at 30°C overnight to ABS 600 ϭ 3.0 in a medium of 2% glucose, 0.67% Yeast Nitrogen Base without amino acids (Difco), adenine (10 g/ml), and amino acids including methionine. Cells from a 5-ml culture were harvested by filtration through a Millipore microtiter filtration plate, washed three times with the same medium lacking methionine, and resuspended in 0.3 ml of 1% glucose, 40 mM potassium phosphate buffer (pH 7.4). [ 35 S]Methionine (100 Ci) was then added. The cells were incubated at 30°C for 5 min, then collected by filtration, and resuspended in 0.4 ml of growth medium containing cycloheximide at 0.5 mg/ml. Samples (0.1 ml) were withdrawn at the indicated time points (Fig. 3) , and added to 0.75 ml of cold buffer A (1% Triton X-100, 0.15 M NaCl, 5 mM EDTA, 50 mM Hepes, pH 7.5, and protein inhibitor cocktail). The cells were immediately disrupted by vortexing with 0.4 ml of glass beads for 1 min alternating with cooling on ice for 1 min for a total of five cycles. The extracts were centrifuged at 12,000g for 3 min, and the radioactivity of acidinsoluble 35 S in the supernatants was measured. Portions of the supernatants containing equal amounts of the acid-insoluble 35 S were added to 60 l of 50% glutathione-agarose beads and rotated at 4°C for 10 min. The beads were washed three times with 1 ml of MTPBS, the protein eluted 3 times with 100 l of Hepes, pH 7.5, containing 5 mM reduced glutathione. Equal amounts of the eluates were subjected to 12% SDS-PAGE and subsequent fluorography.
RESULTS

N-terminal methionine removal patterns of two distinct methionine aminopeptidases.
We generated nine single mutations at the second residue of wildtype GST (Met-Ser-GST) by replacing the Ser residue with known MetAP substrate residues (e.g., Met-Ala-GST, Cys, Gly, Pro, Thr, Val) or non-MetAP substrates residues (e.g., Met-Gln-GST, Glu, or Leu). These sitespecific GST mutant proteins were designated S2X where X stands for the amino acid that replaces the wild-type Ser residue. Wild-type and mutant GST proteins were expressed and purified from the following yeast strains: wild-type (W303-1A), map1⌬ (YS401), map2⌬ (YS402), and map1⌬ overexpressing MAP2 (YS403).
We did not examine all other possible non-MetAP substrates because N-terminal methionine is typically 100% retained when they are expressed in wild-type yeast (7) (8) (9) . Thus, it is likely that the N-terminal methionine will be retained on non-MetAP substrates whether MetAP1 or MetAP2 is absent from the cell.
This was found to be true for three representative non-MetAP substrates tested (Met-Glu-Pro-, Met-GlnPro-, and Met-Leu-Pro-) ( Table I) .
The difference in mass between GST with and without N-terminal methionine was easily distinguished by electrospray ionization mass spectrometry (ESI-MS). No internal standards were analyzed as the relative peaks of GST with and without N-terminal methionine were compared within the same sample. Further, ESI-MS has been demonstrated to be quite reliable for quantitative measurements of analytes within the same sample having a small difference in mass (29) .
The protein masses measured by ESI-MS closely matched those predicted. For example, the calculated mass for the S2P mutant GST with N-terminal Met retained is 26,921 Da and the mass estimated by ESI-MS was 26,923 Ϯ 3 Da. The calculated mass for the S2P mutant protein lacking N-terminal Met is 26,790 Da and the mass estimated by ESI-MS was 26,794 Ϯ 3 Da, consistent with the hydrolytic cleavage of N-terminal methionine.
The extent of Met cleavage was assessed by ESI-MS (Fig. 2) . The degree of Met cleavage was estimated by calculating the ratio of cleaved GST to total GST by the formula: Ser  100  100  30  92  Ala  100  100  54  100  Cys  100  96  10  70  Gly  96  96  5  34  Pro  96  97  20  82  Thr  100  100  10  60  Val  81  78  25 When GST was expressed in wild-type yeast, N-terminal Met was efficiently removed from the steady state protein (Table I) . When the second residue was Ala, Cys, Ser, or Thr, the N-terminal Met was 100% removed. When the second residue was Gly or Pro, over 90% of the Met was removed. However, when the second residue was Val, only 80% of the Met was removed.
When GST was expressed in the map2⌬ strain, the Met cleavage pattern was very similar to that in the wild-type yeast. In contrast, when GST was expressed in the map1⌬ strain, the extent of Met cleavage overall was reduced dramatically. Overexpression of MetAP2 in the map1⌬ strain improved Met cleavage significantly, but MetAP2 was much less effective in the cleavage of Met when the second residue was Cys, Thr, or Gly. These findings indicate that (1) the expression level of MetAP2 can significantly affect the efficiency of Met cleavage in map1⌬, and (2) MetAP1 and MetAP2 have subtle differences in their processing efficiencies in vivo.
Retention of the initiator methionine affects the stability of the S2A mutant protein. The yields of each GST variant expressed in the four yeast strains were very similar, except for the S2A mutant protein. The yield of the S2A protein expressed in map1⌬ was about 10-fold lower than that of other GST variants expressed in all tested yeast strains. This led us to the hypothesis that this mutant protein, when expressed in the map1⌬ strain, has a shorter half-life. To test this hypothesis, we carried out pulse-chase experiments. We found that the half-life of the S2A mutant protein expressed in the map1⌬ strain was indeed only about 10 min, while its half-life when expressed in wild-type yeast was similar to wild-type GST (Ͼ30 min) (Fig. 3) . When wild-type GST (Met-Ser-GST) was expressed in the map1⌬ strain or wild-type yeast, its half-life was not changed (Ͼ30 min). Thus, Met retention does not affect wild-type GST turnover. Together, these findings suggest that retention of the initiator methionine in combination with alanine as the second residue reduces the stability of the S2A mutant protein in vivo.
DISCUSSION
Eukaryotic cells possess two distinct methionine aminopeptidases. To compare the individual processing efficiency of each MetAP in vivo, we generated nine mutant GST proteins, each having a different second residue in the sequence Met-Xaa-Pro-Ile-GST. Based on studies in wild-type yeast, the wild-type GST protein (Xaa ϭ Ser) and six of the GST mutant proteins 
FIG. 2.
Examples of the mass spectra from the S2P GST mutant protein expressed in the four different yeast strains. The S2P GST mutant protein was expressed in the yeast wild-type strain (A), the map2⌬ strain (B), the map1⌬ strain (C), or the map1⌬ strain that overexpresses MetAP2 (D). The molecular mass of each purified mutant protein was determined by electrospray mass spectrometry. An expanded view of the full-scan mass spectrum is shown for each sample and the peaks are an integration of ion chromatograms.
CHEN, VETRO, AND CHANG
(Xaa ϭ Ala, Cys, Gly, Pro, Thr, or Val) are known MetAP substrates, while three (Xaa ϭ Gln, Glu, Leu) are known non-MetAP substrates.
Using ESI-MS, we measured and compared the degree of methionine cleavage for each mutant and wildtype GST protein expressed in a yeast wild-type, map1⌬, map2⌬, or map1⌬ strain overexpressing wildtype MAP2. We found that in the presence of both MetAPs, the N-terminal Met of GST is almost completely removed (Ͼ95%) when the second residue has a radius of gyration of 1.43 Å or less. These results are consistent with previous studies in yeast using altered mutants of endogenous iso-1-cytochrome c (7, 9) or mutants of the plant protein thaumatin (8) . These findings also indicate that the non-endogenous GST mutant proteins were not processed differently than endogenous protein substrates.
N-terminal methionine cleavage efficiency of MetAP1 in vivo.
To examine the processing efficiency of MetAP1 in vivo, we expressed each GST mutant protein in a yeast map2⌬ strain where only MetAP1 is present. The steady state levels of MetAP1 are similar in both the wild-type and map2⌬ strains (data not shown). We found that the pattern of N-terminal methionine removal efficiency was almost identical to wild-type yeast (Xaa: Ser, Ala, Thr Ͼ Pro Ͼ Cys, Gly Ͼ Val). Thus, MetAP1 alone in yeast is sufficient for removing N-terminal methionine under normal growth conditions.
Recently, Walker et al. performed a detailed in vitro study of the yeast MetAP1 substrate specificity (30) . The preference (catalytic efficiency) found for octapeptide substrates (MXSHRWDW, where X ϭ A, C, G, P, S, T, V) in vitro was Ala, Ser Ͼ Gly Ͼ Pro Ͼ Thr Ͼ Val. No activity was detected against the Met-Cys-octapeptide substrate in their study.
Consistent with this study, we found that Met-Val-GST is the worst substrate for MetAP1 in vivo (78% processed in map2⌬). However, studies in vitro have never been successful in detecting activity against a Met-Cys-substrate, presumably due to the interaction between the cobalt ion and the sulfhydryl group of the Cys residue (30) . In vivo, we found that 96% of Nterminal Met is removed when followed by a Cys residue. Complete processing of Met-Cys-substrates in vivo was also reported in yeast for mutants of the plant protein thaumatin (8) and yeast iso-1-cytochrome c mutants (9) . Together, these studies indicate that the metal cation at the MetAP catalytic site is not affected by second-residue cysteine in vivo.
N-terminal methionine cleavage efficiency of MetAP2 in vivo. To examine the processing efficiency of MetAP2 in vivo, we expressed each GST mutant protein in a yeast map1⌬ strain where only MetAP2 is present. The steady state level of MetAP2 in the map1⌬ strain is comparable to MetAP2 in wild-type yeast (data not shown).
We found that the majority of N-terminal Met is retained in the presence of MetAP2 alone. These results indicate that (1) normal levels of MetAP2 are not sufficient for the cellular MetAP activity requirements of yeast, and that (2) MetAP1 is primarily responsible for N-terminal processing in yeast under normal cellular conditions.
We previously observed that overexpression of yeast MetAP2 can partially rescue the slow-growth phenotype of the map1⌬ strain (19) . This suggested that increased steady-state levels of MetAP2 might increase the level of cellular MetAP activity in the absence of MetAP1 activity.
We expressed each GST mutant protein in a map1⌬ strain that overexpresses MetAP2 and compared Met cleavage with that in the map1⌬ strain. Overall, the overexpression of MetAP2 in map1⌬ selectively increased the processing of some substrates (Xaa ϭ Ala, Ser, Pro, and Val) but did not increase the processing of other MetAP substrates (Xaa ϭ Cys, Gly, and Thr). These results indicate that increasing the steady-state level of MetAP2 increases cellular MetAP activity, but does so in a selective manner. Thus, MetAP2 exhibits a different processing efficiency than MetAP1 against the same protein substrates in vivo.
Interestingly, overexpression of MetAP2 in map1⌬ does not compensate well for the cleavage of the MetGly-Pro substrate by MetAP1. N-terminal glycine is myristoylated and required for the proper function of proteins that play important roles in cell signaling and protein trafficking, such as the G (i) family of G ␣ subunit proteins (31) and ADP-ribosylation factor protein 1 (Arf1p) (32) (33) (34) . N-myristoyl transferase (NMT), however, requires removal of N-terminal methionine to expose the N ␣ amino group of the second residue glycine for myristate modification (35) . Thus, if glycine alone is the most important factor in determining the activity of MetAPs, MetAP2 is not expected to play a major role in the maturation of proteins that require N-myristoylation for optimal activity. The finding that total N-myristoylation of proteins was largely unaffected in vascular endothelial cells (VEC) pretreated with a potent inhibitor of MetAP2, TNP-470, is consistent with these results (36) . The only notable exception is endothelial nitric oxide synthase (eNOS), which is found to have decreased myristoylation in VEC after TNP-470 treatment (36, 37) .
Factors affecting MetAP2 processes efficiency in vivo. Based on our findings, we have identified at least two factors that affect MetAP2 processing efficiency in vivo: (1) the steady state level of MetAP2 (2) affect Met removal might involve MetAP2 ribosome association. It is generally presumed that MetAPs are ribosome associated because N-terminal methionine is cotranslationally removed when the nascent polypeptide is 15-20 amino acids in length (38) . We also have biochemical evidence (ribosome profiles) that both yeast MetAP1 and MetAP2 are ribosome-associated proteins (unpublished data). While normal levels of MetAP1 might fully saturate the ribosomes in map2⌬, normal levels of MetAP2 might only partially saturate the ribosomes in map1⌬. It follows then, by mass action, that the overexpression of MetAP2 in map1⌬ increases the concentration of MetAP2 associated with the ribosomes. As a result, a greater percentage of proteins have N-terminal Met removed in map1⌬ overexpressing MetAP2 because sufficient levels of MetAP2 are present at the point where it is most critical: the ribosomes.
Although previous data in vitro has suggested a difference in substrate specificity between MetAP1 and MetAP2, our results give the first evidence that a difference in substrate processing efficiency does indeed exist between MetAP1 and MetAP2 in vivo. This is evidenced by comparison of GST processing patterns in map2⌬ (only MetAP1 present) and map1⌬ overexpressing MetAP2 (only high levels of MetAP2 present), which demonstrates that increased levels of MetAP2 in map1⌬ can efficiently process some (Ala, Pro, Ser, Val) but not all MetAP substrates (Cys, Gly, Thr) in vivo (Table I) . Although the steady state levels of MetAP1 and MetAP2 were not directly compared, these results demonstrate that MetAP2 exhibits a preference for specific substrates in vivo that differ only in the second residue.
It is worth noting that proline at position three (as is found in GST) has been reported to inhibit Met removal in yeast when the second residue has an intermediate radius of gyration (e.g., Met-Val-Pro-, MetThr-Pro-) (7, 9) . A mutant of human hemoglobin with the sequence Met-Val-Pro-that completely inhibits Met removal was also reported (39) . In contrast, we found that Met-Thr-Pro-GST is fully processed (100%) while Met-Val-Pro-GST is processed to a lesser extent (81%). Together, these results support the proposal that amino acids downstream of Pro (secondary structures) additionally affect MetAP N-terminal processing in vivo (7) . Evidence of this has also been observed in vitro, as both the peptide length and primary sequence have been shown to affect the catalytic activity of both MetAP1 and MetAP2 against the same peptide substrate (18, 30, 36) .
The contribution of MetAP ribosome association and ribosome interactions with the nascent polypeptide cannot be overlooked and may further account for processing differences observed between different proteins having the same penultimate residue. These interactions may also account for differences in MetAP substrate specificity observed in vitro and in vivo (36) .
Effect of methionine removal on protein turnover. It is important to note that the cleavage ratio for MetAla-GST (54%) is likely overestimated because the Met-Ala-GST protein has a shorter half-life than Ala-GST. The destabilization of Met-Ala-GST, however, does not follow the N-end rule.
According to the N-end rule, the half-life of a protein depends on its N-terminal residue and involves the ubiquitin-dependent pathway. N-terminal methionine is one of several amino acids considered a stabilizing residue (40) . However, we found that the half-life of the S2A mutant protein expressed in the map1⌬ strain was drastically lower than that of wild-type GST expressed in map1⌬. In contrast, the half-life of the S2A mutant protein expressed in wild-type type yeast had a similar stability to wild-type GST. Considering that a little over half of S2A isolated from map1⌬ had Met removed (54%) while S2A isolated from wild-type yeast had Met completely removed (100%), it is most likely that N-terminal Met retention plus the S2A mutation are jointly causing the fast turnover of this particular mutant protein. It would be very interesting to determine whether the S2A mutant protein is degraded via the ubiquitin-dependent pathway in the map1⌬ strain.
It should be emphasized that the destabilization by the N-end rule only affects proteins that have been processed by endoproteases and will not impact proteins processed by MetAP alone. This is because the initial determinant of N-terminal Met removal is the second residue in the protein's primary sequence (e.g., Met-Ala-, -Cys-, -Gly-, -Pro-, -Ser-, -Thr-, -Val-). According to the N-end rule, these are also considered stabilizing N-terminal residues (40) . As a result, any protein that has its N-terminal Met removed by MetAP will still retain a stabilizing N-terminal residue. In addition, N-terminal residues considered destabilizing (e.g., Phe, Tyr, etc.) are non-MetAP substrates. Thus, these proteins will not be processed by MetAP and will retain the stabilizing N-terminal Met residue.
The effect of MetAP2 on protein turnover may have broader implications in relation to the role of MetAP2 in vascular endothelial cells. Derivatives of fumagillin, a potent angiogenesis inhibitor, were found to target and irreversibly inhibit mammalian MetAP2 in vascular endothelial cells (VEC) (36, 41, 42) . The inhibition of MetAP2 correlates strongly with the inhibition of VEC growth, suggesting a mechanism of growth arrest that results from MetAP2 inactivation (36) . The cytostatic inhibition of EC in late G 1 phase (43) was found to require p53 and p21 WAF1/CIP1 (44, 45) . The mechanism by which the p53 pathway is activated in response to MetAP2 inhibition, however, remains unclear at this time. Considering that N-terminal Met retention may 92 affect the turnover rate of certain proteins, it would be of great interest to determine whether TNP-470 treatment affects the half-life of any vascular endothelial cell proteins. These proteins may, in turn, be potential downstream targets of TNP-470 and lead to novel antiangiogenesis strategies.
